BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Durczynski A, Kumor A, Hogendorf P, Szymanski D, Grzelak P, Strzelczyk J. Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer. World J Gastroenterol 2014; 20(36): 13167-13171 [PMID: 25278712 DOI: 10.3748/wjg.v20.i36.13167]
URL: https://www.wjgnet.com/1007-9327/full/v20/i36/13167.htm
Number Citing Articles
1
Dorothée Faille, Marie-Charlotte Bourrienne, Emmanuelle de Raucourt, Luc de Chaisemartin, Vanessa Granger, Romaric Lacroix, Laurence Panicot-Dubois, Pascal Hammel, Philippe Lévy, Philippe Ruszniewski, Nadine Ajzenberg, Vinciane Rebours. Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer processOncotarget 2018; 9(41): 26453 doi: 10.18632/oncotarget.25458
2
Junli Cao, Zhanzhao Fu, Liming Gao, Xin Wang, Shaohui Cheng, Xiuchao Wang, He Ren. Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinomaWorld Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1104-9
3
Cristina Jimenez-Luna, Carolina Torres, Raul Ortiz, Carmelo Dieguez, Joaquina Martinez-Galan, Consolacion Melguizo, Jose C. Prados, Octavio Caba. Proteomic biomarkers in body fluids associated with pancreatic cancerOncotarget 2018; 9(23): 16573 doi: 10.18632/oncotarget.24654
4
Florian Moik, Gerald Prager, Johannes Thaler, Florian Posch, Sarah Wiedemann, Theresa Schramm, Cornelia Englisch, Nigel Mackman, Ingrid Pabinger, Cihan Ay. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic CancerArteriosclerosis, Thrombosis, and Vascular Biology 2021; 41(11): 2837 doi: 10.1161/ATVBAHA.121.316463
5
Adam Durczynski, Anna Kumor, Piotr Grzelak, Marcin Strzelczyk, Piotr Hogendorf, Grazyna Poznanska, Aleksander Skulimowski, Dariusz Szymanski, Janusz Strzelczyk. Concentration of D-dimers in Bile—a Novel Marker of Pancreatic Cancer Enhancing Accuracy of Standard CA19-9 MeasurementPancreas 2017; 46(1): e9 doi: 10.1097/MPA.0000000000000696
6
Marina Marchetti, Anna Falanga. Hemostatic biomarkers in occult cancer and cancer risk predictionThrombosis Research 2020; 191: S37 doi: 10.1016/S0049-3848(20)30395-9
7
Haoda Chen, Fanlu Li, Siyi Zou, Junjie Xie, Jun Zhang, Xiaxing Deng, Hao Chen, Baiyong Shen. Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resectionWorld Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02281-8
8
Hadi M.H. Diab, Henry G. Smith, Kristian K. Jensen, Lars N. Jørgensen. The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic reviewEuropean Journal of Cancer 2021; 154: 73 doi: 10.1016/j.ejca.2021.05.033
9
Carla F. Pereira, M. Goreti F. Sales, Manuela F. Frasco. A molecularly imprinted photonic polymer based on an inverse opal structure for sensing D-dimer at the point-of-careTalanta 2022; 243: 123387 doi: 10.1016/j.talanta.2022.123387
10
Alicja Strzałka, Piotr Hogendorf, Aleksander Skulimowski, Michał Spychalski, Janusz Strzelczyk, Adam Durczynski. Thyroid hormones concentration in portal and peripheral blood in patients with pancreatic cancer: Preliminary studyCancer Biomarkers 2020; 29(3): 301 doi: 10.3233/CBM-201595
11
Adam Durczynski, Aleksander Skulimowski, Piotr Hogendorf, Dariusz Szymanski, Anna Kumor, Konrad Marski, Siri Øvereng Juliebø, Grazyna Poznanska, Janusz Strzelczyk. The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancerWorld Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1291-4
12
Xinchun Liu, Yue Fu, Qiuyang Chen, Junli Wu, Wentao Gao, Kuirong Jiang, Yi Miao, Jishu Wei. Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancerBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0891-y
13
Nora Mattila, Hanna Seppänen, Harri Mustonen, Beata Przybyla, Caj Haglund, Riitta Lassila. Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal AdenocarcinomaClinical and Applied Thrombosis/Hemostasis 2018; 24(8): 1267 doi: 10.1177/1076029618779133
14
Iranzu González-Boja, Antonio Viúdez, Saioa Goñi, Enrique Santamaria, Estefania Carrasco-García, Jairo Pérez-Sanz, Irene Hernández-García, Pablo Sala-Elarre, Virginia Arrazubi, Esther Oyaga-Iriarte, Ruth Zárate, Sara Arévalo, Onintza Sayar, Ruth Vera, Joaquin Fernández-Irigoyen. Omics Approaches in Pancreatic AdenocarcinomaCancers 2019; 11(8): 1052 doi: 10.3390/cancers11081052
15
Jing Yu, Dongqing Li, Dansheng Lei, Feng Yuan, Feng Pei, Huifeng Zhang, Anming Yu, Kun Wang, Hu Chen, Liang Chen, Xianglei Wu, Xianli Tong, Yefu Wang, Robert Hurst. Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional StudyPLOS ONE 2016; 11(11): e0165390 doi: 10.1371/journal.pone.0165390
16
Aneta Szmiel, Alicja Majos, Wojciech Ciesielski, Anna Kumor, Janusz Strzelczyk, Krzysztof Szwedziak, Piotr Hogendorf, Adam Durczyński. Gender-Specific Coagulation Profiles of Peripheral and Portal Blood May Help to Differentiate Malignant from Benign Pancreatic Tumour—Pilot StudyJournal of Clinical Medicine 2022; 11(6): 1573 doi: 10.3390/jcm11061573
17
Arturs Silovs, Ilze Strumfa, Reinis Riekstins, Zane Simtniece, Andrejs Vanags, Janis Gardovskis. Advances in Pancreatic Cancer2018;  doi: 10.5772/intechopen.78954